Acuitas Therapeutics is a Canadian biotechnology company and the global leader in lipid nanoparticle (LNP) delivery technology. Their LNP technology is used in two approved products (ONPATTRO and COMIRNATY). They operate on a strategic partnership model, licensing their LNP platform to pharma and biotech partners rather than manufacturing drugs. They do not function as a CDMO; they are a technology platform company that partners with CDMOs for manufacturing.
Lipid nanoparticle (LNP) delivery technology, mRNA delivery, Nucleic acid therapeutics delivery, Formulation optimization
1 site worldwide
No certifications on file yet.
No reviews available yet.
No documents available.